PLoS ONE (Jan 2017)

Association of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes.

  • Tomomi Murai,
  • Noriko Takebe,
  • Kan Nagasawa,
  • Yusuke Todate,
  • Riyuki Nakagawa,
  • Rieko Nakano,
  • Mari Hangai,
  • Yutaka Hasegawa,
  • Yoshihiko Takahashi,
  • Kunihiro Yoshioka,
  • Yasushi Ishigaki

DOI
https://doi.org/10.1371/journal.pone.0184723
Journal volume & issue
Vol. 12, no. 9
p. e0184723

Abstract

Read online

Accumulation of epicardial adipose tissue (EAT) is considered to be a cardiovascular risk factor independent from visceral adiposity, obesity, hypertension and diabetes. We explored the parameters related to EAT accumulation, aiming to clarify the novel pathophysiological roles of EAT in subjects with type 2 diabetes (T2DM).We examined the laboratory values, including cystatinC, and surrogate markers used for evaluating atherosclerosis. EAT was measured as the sum of the adipose tissue area, obtained by plain computed tomography scans in 208 subjects with T2DM but no history of coronary artery disease.EAT correlated positively with age, body mass index (BMI), visceral fat area, leptin, cystatin C and C-peptide, while correlating negatively with adiponectin, estimated glomerular filteration rate (eGFR) and the liver-to-spleen ratio. Multiple linear regression analysis revealed serum cystatin C (β = 0.175), leptin (β = 0.536), BMI (β = 0.393) and age (β = 0.269) to be the only parameters showing independent statistically significant associations with EAT. When cystatin C was replaced with eGFR, eGFR showed no significant correlation with EAT. In reverse analysis, serum cystatin C was significantly associated with EAT after adjustment in multivariate analysis.EAT accumulation and elevated cystatin C have been independently regarded as risk factors influencing atherosclerosis. The strong association between EAT and cystatin C demonstrated herein indicates that EAT accumulation may play an important role in Cystatin C secretion, possibly contributing to cardiometabolic risk in T2DM patients.